Company: CI
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001739940-25-000009
Chunk: 913

Company: Cigna Group
Filing Date: 2025-02-27
Form: 10-K
Item: Item 2
Chunk 913
---
10 %

39

Reconciliation of Shareholders' Net Income (GAAP) to Adjusted Income from OperationsFor the Years Ended December 31,202420232022(In millions)Pre-taxAfter-taxPre-taxAfter-taxPre-taxAfter-taxShareholders' net income$3,434 $5,164 $6,704 Adjustments to reconcile to adjusted income from operationsNet investment losses (1)$2,533 2,529 $135 114 $613 496 Amortization of acquired intangible assets1,703 1,347 1,819 1,413 1,876 1,345 Special itemsIntegration and transaction-related costs275 211 45 35 135 103 Impairment of dividend receivable 182 138 — — — — Deferred tax expenses (benefits), net— 84 — (1,071)— — Net (gain) loss on sale of businesses (24)(2)1,499 1,429 (1,662)(1,332)Charge for organizational efficiency plan— — 252 193 22 17 Charges (benefits) associated with litigation matters— — 201 171 (28)(20)Total special items$433 431 $1,997 757 $(1,533)(1,232)Adjusted income from operations$7,741 $7,448 $7,313 

(1)Includes Net investment gains/losses as presented in our Consolidated Statements of Income, as well as the Company's share of certain investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting, which are presented within Fees and other revenues in our Consolidated Statements of Income.

Reconciliation of Shareholders' Net Income (GAAP) to Adjusted Income from OperationsFor the Years Ended December 31,202420232022(Diluted earnings per share)Pre-taxAfter-taxPre-taxAfter-taxPre-taxAfter-taxShareholders' net income$12.12 $17.39 $21.41 Adjustments to reconcile to adjusted income from operationsNet investment losses (1)$8.95 8.93 $0.45 0.38 $1.96 1.59 Amortization of acquired intangible assets6.01 4.76 6.13 4.77 5